Patient partnerships

Our work is destined to have a direct impact on people living with heart attack and heart failure, their carers and families. These people have valuable lived experience that can help shape our research questions, approach and engagement. We recognise the …

Governance

The MRC/BHF CoRE in Advanced Cardiac Therapies began on 1 January 2025, with a duration of 14 years. Funding has been secured for an initial 7 year period. An experienced leadership team are responsible for delivering CoRE research and impact. Day-to-day …

Professor Eric Olson

Eric N. Olson PhD is the founding Chair of the Department of Molecular Biology at the University of Texas Southwestern Medical Center and founding chair of the Department of Molecular Biology at the University of Texas Southwestern Medical Center. He also …

Dr Martin Murphy

Martin Murphy is a life science investor. He was formerly co-founder and CEO of Syncona, and a director and founding investor of Autolus Therapeutics. He holds a PhD from the University of Cambridge and an MA in Biochemistry from the University of Oxford. …

Dr Lauren Tedaldi

Lauren Tedaldi is Head of Research and Innovation Communications at Great Ormond Street Hospital for Children NHS Foundation Trust. Lauren has been a member of REACT's Independent Strategic Advisory Board since …

Amol Bhatnagar

Amol Bhatnagar is a civil engineer and person with lived experience of heart attack. Amol has been a member of REACT's Independent Strategic Advisory Board since …

Professor Sheila Francis

Sheila Francis is Professor of Cardiovascular Biology and Faculty of Health Director of One University Strategy Delivery at the University of Sheffield. Sheila has been a member of REACT's Independent Strategic Advisory Board since …